6-Bromo-3-ethyl-3H-imidazo[4,5-b]pyridine

Catalog No. :
ACBILE459
CAS No. :
1033202-59-3
Molecular Formula :
C8H8BrN3
Molecular Weight :
226.08

IUPAC Name:6-bromo-3-ethyl-3H-imidazo[4,5-b]pyridine

6-Bromo-3-ethyl-3H-imidazo[4,5-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$69.00Login to see priceIn stockInquiry
5g98%$240.00Login to see priceIn stockInquiry
25g98%$719.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-3-ethyl-3H-imidazo[4,5-b]pyridine
IUPAC Name6-bromo-3-ethyl-3H-imidazo[4,5-b]pyridine
MDL No.B178924
Molecular FormulaC8H8BrN3
Molecular Weight226.08
SMILESCCN1C=NC2=CC(Br)=CN=C21
InChI KeyQHFMKLXEVDGSFU-UHFFFAOYSA-N
Synonym6-Bromo-3-ethyl-3H-imidazo[4,5-b]pyridine | 1033202-59-3 | 6-bromo-3-ethylimidazo[4,5-b]pyridine | DTXSID70632690 | BCP31087 | MFCD08692128 | AKOS015834477 | BS-25999 | CS-0212056
CAS No.1033202-59-3
PubChem CID23298303

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBILE459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJWPA208 route compound structure diagram
    ACJWPA20828279-49-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBILE459 route product structure diagram
    ACBILE4591033202-59-3 In Stock
Inquiry

2. ACBILE459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJWPA208 route compound structure diagram
    ACJWPA20828279-49-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBILE459 route product structure diagram
    ACBILE4591033202-59-3 In Stock
Inquiry

Comments (0)